Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

2.2.1 Live Vaccines

2.2.2 Killed Vaccines

2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type

2.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Type (2017-2022)

2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

2.4.1 Government Tender

2.4.2 Market Sales

2.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application

2.5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Application (2017-2022)

3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company

3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Breakdown Data by Company

3.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2020-2022)

3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Company

3.4 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Location Distribution

3.4.2 Players Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Geographic Region

4.1 World Historic Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Revenue by Geographic Region

4.2 World Historic Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Revenue by Country/Region

4.3 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth

4.4 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth

4.5 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth

4.6 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth

5 Americas

5.1 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country

5.1.1 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022)

5.1.2 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022)

5.2 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type

5.3 Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region

6.1.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022)

6.1.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022)

6.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type

6.3 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country

7.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022)

7.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022)

7.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type

7.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country

8.1.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type

8.3 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

10.3 Manufacturing Process Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

10.4 Industry Chain Structure of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors

11.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customer

12 World Forecast Review for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Geographic Region

12.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Region

12.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast by Region (2023-2028)

12.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast by Type

12.7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast by Application

13 Key Players Analysis

13.1 CAHIC

13.1.1 CAHIC Company Information

13.1.2 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CAHIC Main Business Overview

13.1.5 CAHIC Latest Developments

13.2 Merial

13.2.1 Merial Company Information

13.2.2 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merial Main Business Overview

13.2.5 Merial Latest Developments

13.3 MSD Animal Health

13.3.1 MSD Animal Health Company Information

13.3.2 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 MSD Animal Health Main Business Overview

13.3.5 MSD Animal Health Latest Developments

13.4 Chopper Biology

13.4.1 Chopper Biology Company Information

13.4.2 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Chopper Biology Main Business Overview

13.4.5 Chopper Biology Latest Developments

13.5 Ceva

13.5.1 Ceva Company Information

13.5.2 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ceva Main Business Overview

13.5.5 Ceva Latest Developments

13.6 ChengDu Tecbond

13.6.1 ChengDu Tecbond Company Information

13.6.2 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 ChengDu Tecbond Main Business Overview

13.6.5 ChengDu Tecbond Latest Developments

13.7 Veterinary

13.7.1 Veterinary Company Information

13.7.2 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.7.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Veterinary Main Business Overview

13.7.5 Veterinary Latest Developments

13.8 Ringpu Biology

13.8.1 Ringpu Biology Company Information

13.8.2 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ringpu Biology Main Business Overview

13.8.5 Ringpu Biology Latest Developments

13.9 Qilu Animal

13.9.1 Qilu Animal Company Information

13.9.2 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Qilu Animal Main Business Overview

13.9.5 Qilu Animal Latest Developments

13.10 DHN

13.10.1 DHN Company Information

13.10.2 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 DHN Main Business Overview

13.10.5 DHN Latest Developments

13.11 CAVAC

13.11.1 CAVAC Company Information

13.11.2 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.11.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 CAVAC Main Business Overview

13.11.5 CAVAC Latest Developments

13.12 Komipharm

13.12.1 Komipharm Company Information

13.12.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.12.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Komipharm Main Business Overview

13.12.5 Komipharm Latest Developments

13.13 Agrovet

13.13.1 Agrovet Company Information

13.13.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.13.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Agrovet Main Business Overview

13.13.5 Agrovet Latest Developments

13.14 Bioveta

13.14.1 Bioveta Company Information

13.14.2 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.14.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bioveta Main Business Overview

13.14.5 Bioveta Latest Developments

13.15 Jinyu Bio-Technology

13.15.1 Jinyu Bio-Technology Company Information

13.15.2 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.15.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Jinyu Bio-Technology Main Business Overview

13.15.5 Jinyu Bio-Technology Latest Developments

13.16 Institutul Pasteur

13.16.1 Institutul Pasteur Company Information

13.16.2 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.16.3 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Institutul Pasteur Main Business Overview

13.16.5 Institutul Pasteur Latest Developments

13.17 MVP

13.17.1 MVP Company Information

13.17.2 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.17.3 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 MVP Main Business Overview

13.17.5 MVP Latest Developments

13.18 Tecon

13.18.1 Tecon Company Information

13.18.2 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.18.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Tecon Main Business Overview

13.18.5 Tecon Latest Developments

13.19 Zoetis

13.19.1 Zoetis Company Information

13.19.2 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

13.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Zoetis Main Business Overview

13.19.5 Zoetis Latest Developments

14 Research Findings and Conclusion

Table 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Vaccines

Table 4. Major Players of Killed Vaccines

Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)

Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)

Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2017-2022)

Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company (2020-2022) & (K Units)

Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Producing Area Distribution and Sales Area

Table 21. Players Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered

Table 22. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)

Table 34. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)

Table 38. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)

Table 40. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)

Table 42. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)

Table 46. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)

Table 48. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)

Table 50. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)

Table 54. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)

Table 56. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Table 66. Key Market Challenges & Risks of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Table 67. Key Industry Trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Table 68. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List

Table 71. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customer List

Table 72. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Forecast by Region

Table 74. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. CAHIC Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 94. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. CAHIC Main Business

Table 96. CAHIC Latest Developments

Table 97. Merial Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 99. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Merial Main Business

Table 101. Merial Latest Developments

Table 102. MSD Animal Health Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 104. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. MSD Animal Health Main Business

Table 106. MSD Animal Health Latest Developments

Table 107. Chopper Biology Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 109. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Chopper Biology Main Business

Table 111. Chopper Biology Latest Developments

Table 112. Ceva Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 114. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. ChengDu Tecbond Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 119. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. ChengDu Tecbond Main Business

Table 121. ChengDu Tecbond Latest Developments

Table 122. Veterinary Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 124. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Veterinary Main Business

Table 126. Veterinary Latest Developments

Table 127. Ringpu Biology Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 129. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Ringpu Biology Main Business

Table 131. Ringpu Biology Latest Developments

Table 132. Qilu Animal Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 134. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Qilu Animal Main Business

Table 136. Qilu Animal Latest Developments

Table 137. DHN Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 139. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. DHN Main Business

Table 141. DHN Latest Developments

Table 142. CAVAC Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 144. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. CAVAC Main Business

Table 146. CAVAC Latest Developments

Table 147. Komipharm Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 149. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Komipharm Main Business

Table 151. Komipharm Latest Developments

Table 152. Agrovet Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 154. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Agrovet Main Business

Table 156. Agrovet Latest Developments

Table 157. Bioveta Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 159. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Bioveta Main Business

Table 161. Bioveta Latest Developments

Table 162. Jinyu Bio-Technology Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 164. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Jinyu Bio-Technology Main Business

Table 166. Jinyu Bio-Technology Latest Developments

Table 167. Institutul Pasteur Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 169. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Institutul Pasteur Main Business

Table 171. Institutul Pasteur Latest Developments

Table 172. MVP Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 174. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. MVP Main Business

Table 176. MVP Latest Developments

Table 177. Tecon Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 178. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 179. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Tecon Main Business

Table 181. Tecon Latest Developments

Table 182. Zoetis Basic Information, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 183. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

Table 184. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Zoetis Main Business

Table 186. Zoetis Latest Developments

List of Figures

Figure 1. Picture of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Figure 2. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Vaccines

Figure 10. Product Picture of Killed Vaccines

Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type in 2021

Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Consumed in Government Tender

Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market: Government Tender (2017-2022) & (K Units)

Figure 15. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Consumed in Market Sales

Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market: Market Sales (2017-2022) & (K Units)

Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)

Figure 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application in 2021

Figure 19. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company in 2021

Figure 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Geographic Region in 2021

Figure 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2022)

Figure 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country/Region in 2021

Figure 25. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2022 (K Units)

Figure 26. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2022 ($ Millions)

Figure 27. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2022 (K Units)

Figure 28. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2022 (K Units)

Figure 30. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country in 2021

Figure 34. Americas Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country in 2021

Figure 35. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region in 2021

Figure 40. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Regions in 2021

Figure 41. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country in 2021

Figure 48. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country in 2021

Figure 49. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country in 2021

Figure 56. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in 2021

Figure 62. Manufacturing Process Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Figure 63. Industry Chain Structure of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles